Scientists from the Bioeconomy Science Institute have discovered that supplementation with New Zealand-grown Boysenberry and apple powder may reduce throat irritation and accelerate recovery from ozone air pollution.
Recently published in Hygiene and Environmental Health Advances, the trial investigated the effects of BerriQi®, a proprietary ingredient made by blending freeze-dried Boysenberries and apple powder, on healthy adults exposed to ozone, a common air pollutant known to impair lung function and cause respiratory irritation.
While often associated with long-term health issues, even short-term exposure can cause discomfort and inflammation in otherwise healthy individuals.
“We know air pollution is a growing concern globally, and our study provides evidence that BerriQi may help alleviate some of the discomfort caused by exposure to ozone pollution,” said Dr Dominic Lomiwes, lead researcher for the study at the Bioeconomy Science Institute.
“It’s exciting to see how compounds naturally found in fruit, like those in boysenberries and apples, can have a real and measurable effect on the body’s response to environmental stress, highlighting the potential for a natural, New Zealand-grown food supplement to support respiratory health."
In the study, participants consumed either BerriQi or a placebo for five days before spending two hours in a sealed chamber with controlled concentrations of ozone gas, simulating real-world acute exposure to air pollution.
The results showed participants who had taken BerriQi reported significantly less throat irritation than those given a placebo. Other symptoms, such as shortness of breath and coughing discomfort, also resolved more quickly in the BerriQi group.
“At Anagenix, we are dedicated to providing natural, scientifically proven solutions for respiratory health. Multiple studies, including direct comparisons, have demonstrated that BerriQi’s unique, patented blend of New Zealand-grown Boysenberry and apple delivers greater respiratory benefits, unmatched by Boysenberry stand alone,” said Chris Johnson, Managing Director of Anagenix.
“This synergistic combination harnesses a broader spectrum of polyphenols and antioxidants, resulting in a significantly stronger ability to accelerate recovery from respiratory challenges. The latest clinical findings reinforce our commitment to developing evidence-based solutions, with further clinical research already planned to evaluate BerriQi’s potential for children’s immunity and its impact on reducing lung nodules.”
The study was funded by the High-Value Nutrition National Science Challenge, supported by the Ministry of Business, Innovation and Employment. A second cohort is now being studied to strengthen and extend the findings.
Additional data on oxidative stress, inflammation, lung function, and polyphenol bioavailability will provide deeper insight into how BerriQi aids recovery from ozone-induced decrements in respiratory health through antioxidant and immune-modulatory mechanisms.
More local news here
